Global Innovative Platforms Inc. (GIPL) Stock
Global Innovative Platforms Inc. engages in the business of testing breath to detect and assist in the treatment of disease.
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Cash Flow (USD)
Valuation & Return Ratios
Ownership
Peer Comparison
About Global Innovative Platforms Inc.
Global Innovative Platforms Inc. engages in the business of testing breath to detect and assist in the treatment of disease. The company develops Heartworm breath test, which includes breath collection device, to collect shallow breath samples. It also operates VOCAM Plus and FROG platform for gas chromatography, as well as operates A.I. software to provide breath and air analysis. The company was formerly known as Canning Str Corp. and changed its name to Global Innovative Platforms Inc. in September 2021. Global Innovative Platforms Inc. was incorporated in 2020 and is based in Sanford, Florida.
Global Innovative Platforms Inc. is headquartered in US.
Global Innovative Platforms Inc. (GIPL) stock trades at $0.50 with a market capitalization of $22.75M. The stock is valued at a price-to-earnings (P/E) ratio of -33.33, price-to-book of 36.60, price-to-sales of 166.63. Over the past 52 weeks the stock has ranged between $0.11 and $0.99, and currently trades 49.5% below its 52-week high.
On profitability, Global Innovative Platforms Inc. generates a return on equity (ROE) of -231.52%, return on capital employed of -109.76%, an operating margin of -474.18%, a net profit margin of -474.18%.
Official website: giplinc.com